2007-2018 Publications
첨부파일 | - |
---|
Publications (Citation: >~13,000; H-index: 51, by google scholar as of May 13, 2018)
[2018]
143. Lee Y, Lee S and Jon S*, “Biotinylated Bilirubin Nanoparticles as a Tumor Microenvironment-responsive Drug Delivery System for Targeted Cancer Therapy”, Adv. Science. 2018; in press. (IF: 9.034) (Epub April 24)
142. Lee S, Lee Y, Kim H, Lee DY and Jon S*, “Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy”, Biomacromolecules. 2018; in press. (IF: 5.246) (Epub May 4)
141. Park S, Jeong JE, Le VS, Seo J, Yu B, Kim DY, Kwon SH, Jon S and Woo HY* and Yang H*, “Enhanced Electron Transfer Mediated by Conjugated Polyelectrolyte and Its Application to Washing-Free DNA Detection”, J. Am. Chem. Soc. 2018; 140(7):2409-2412. (IF: 13.858) (Epub Feb 8)
140. Kim Y, Choi M, Mulay SV, Jang M, Kim JY, Lee WH, Jon S and Churchill DG*, “Aqueous red emission probe for the selective fluorescent detection of cysteine by deprotection/cyclization cascade resulting in large Stokes’ shift”, Chemistry 2018; 24(21):5623-5629. (IF: ) (Epub Mar 5)
139. Mulay SV, Kim Y, Choi M, Lee DY, Choi J, Lee Y, Jon S and Churchill DG*, “Enhanced Doubly Activated Dual Emission Fluorescent Probes for Selective Imaging of Glutathione or Cysteine in Living Systems”, Anal Chem 2018; 90(4): 2648-2654. (IF: 6.320) (Epub Feb 6)
[2017]
138. Jeon H, Kim D, Choi M, Kang S, Kim JY, Kim S* and Jon S*, “Targeted cancer therapy using a fusion protein of TNF and a tumor-associated fibronectin-specific aptide”, Mol Pharm 2017; 14(11): 3772-3779. (IF: 4.44) (Nov 6; Epub Oct 11)
137. Lee DY, Kim JY, Lee S, Miao W, Kim HS, Min JJ and Jon S*, “Black pigment gallstone-inspired platinum-chelated bilirubin nanoparticles for combined photoacoustic imaging and photothermal therapy of cancers”, Angew. Chem. Int. Ed. 2017; 56(44): 13684-13688. (IF: 11.994) (Oct 23; Epub Sep 4)
136. Yoo J, Sanoj Rejinold N, Lee D, Jon S and Kim YC*, “Protease-activatable cell-penetrating peptide processing ROS-triggered phase transition for enhanced cancer therapy”, J. Control. Release 2017; 264, 89-101. (IF: 7.786) (Aug 24)
135. Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, Jon S, Fisher EA and Farokhzad OC*, “Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in LdIr-/- Mice”, Adv. Healthc. Mater. 2017; in press. (IF: 5.11) (Epub Jul 21)
134. Kim DE,1 Lee Y,1 Kim M, Lee S, Jon S* and Lee SH*, “Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma”, Biomaterials 2017; 140, 37-44. (IF: 8.402) (Epub Jun 12) (1Equal contribution)
133. Keum H, Kim JY, Yu B, Yu SJ, Kim J, Jeon H, Lee DY, Im SG and Jon S*, “Prevention of Bacterial Colonization on Catheters by a One-Step Process Involving an Antibiofouling Polymer in Water”, ACS Appl. Mater. Interfaces 2017; 9(23), 19736-19745. (IF: 7.145) (Epub Jun 1)
132. Kim J,1 Kim H,1 Park JH* and Jon S*, “Gold Nanorod-based Photo-PCR System for One-Step, Rapid Detection of Bacteria”, Nanotheranostics 2017; 1(2), 178-185. (IF: ) (May 6) (1Equal contribution)
131. Kim D, Jeon H, Ahn S, Choi WI, Kim S* and Jon S*, “An approach for half-life extension and activity preservation of an anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide”, J. Control. Release 2017; 256: 114-120. (IF: 7.786) (Apr 27)
130. Kim MJ, Lee Y, Jon S and Lee DY*, “PEGylated bilirubin nanoparticle as an anti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation”, Biomaterials 2017; 133: 242-252. (IF: 8.402) (Jul, Epub Apr 18)
129. Kang S, Ahn S, Lee J, Kim JY, Choi M, Gurati V, Kim H, Kim J, Shin EC* and Jon S*, “Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses”, J. Control. Release 2017; 256: 56-67. (IF: 7.786) (Apr 18)
128. Kim JY, Lee DY, Kang S, Miao W, Kim H, Lee Y and Jon S*, “Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury”, Biomaterials 2017; 133: 1-10. (IF: 8.402) (Jul, Epub Apr 12)
127. Lee Y, Kim S, Kim D and Jon S*, “A histone H-binding-aptide-based apoptosis imaging probe for monitoring tumor responses to cancer therapy”, MedChemComm. 2017: 8, 390. (IF: 2.319) (Epub Jan 05)
126. Fang CS, Kim KS, Yu B, Jon S, Kim MS and Yang H*, “Ultrasensitive Electrochemical Detection of miRAN-21 Using a Zinc Finger Protein Specific to DNA-RNA Hybrids”, Anal. Chem. 2017; 89(3): 2024-2031. (IF: 5.886) (Feb 7, Epub Jan 6)
125. Saw PE, Yu M, Choi M, Lee E, Jon S* and Farokhzad OC*, “Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy”, Biomaterials 2017; 123: 118-126. (IF: 8.402) (Apr, Epub Jan 31)
[2016]
124. Mulay SV, Yudhistira T, Choi M, Kim Y, Jang YJ, Jon S and Churchill DG*, “Substituent Effects in BODIPY in Live Cell Imaging”, Chem Asian J. 2016: in press. (IF: 4.592) (Epub 2016 Nov 11)
123. Yu SB, Baek J, Choi M, Oh Y, Lee HR, Yu SJ, Lee E, Sohn JW, Im SG* and Jon S*, “Polymer Thin Films with Tunable Acetylcholine-Like Functionality Enable Long-Term Culture of Primary Hippocampal Neurons”, ACS Nano 2016: in press. (IF: 13.334) (Epub 2016 Nov 1)
122. Saw PE, Park J, Jon S* and Farokhzad OC*, “A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectin”, Nanomedicine 2016: in press. (IF: 5.671) (Epub 2016 Oct 18)
121. Kim H, Lee Y, Kang S, Choi M, Lee S, Kim S, Gujrati V, Kim J and Jon S* “Self-assembled nanoparticles comprising aptide-SN38 conjugates for used in targeted cancer therapy”, Nanotechnology 2016: 27(48), 48LT01. (IF: 3.573) (Epub 2016 Nov 2)
118. Mulay SV, Choi M, Jang YJ, Kim Y, Jon S and Churchill DG*. “Enhanced Fluorescence Turn-on Imaging of Hypochlorous Acid in Living Immune and Cancer Cells”, Chemistry - A European Journal 2016; (IF: 3.585) (Epub 2016 May 31)
117. Yoo J, Lee D, Gujrati V, Rejinold NS, Lekshmi KM, Uthaman S, Jeong C, Park IK, Jon S and Kim YC*. “Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform”, J. Control. Release 2016: in press. (IF: 7.705) (Epub 2016 May 8)
116. Lee Y, Kim H, Kang S, Lee J, Park J and Jon S*, “Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy”, Angew. Chem. Int. Ed. 2016: 55(26), 7460-3. (IF: 11.709) (Jun 20)
115. Lee J, Saw PE, Gujrati V, Lee Y, Kim H, Kang S, Choi M, Kim JI, Jon S. “Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.” Theranostics. 2016 Jan 1;6(2):192-203.
114. Gujrati V, Lee M, Ko YJ, Lee S, Kim D, Kim H, Kang S, Lee S, Kim J, Jeon H, Kim SC, Jun Y, Jon S. “Bioengineered yeast-derived vacuoles with enhanced tissue-penetrating ability for targeted cancer therapy.” Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):710-5.
[2015]
113. Sun Y, Kim HS, Saw PE, Jon S, Moon WK. “Targeted Therapy for Breast Cancer Stem Cells by Liposomal Delivery of siRNA against Fibronectin EDB.” Adv Healthc Mater. 2015 Aug 5;4(11):1675-80.
65. Kim BK, Yang SY, Aziz MA, Jo K, Sung D, Jon S, Woo HY and Yang H*. "Electrochemical Immunosensing Chip Using Selective Surface Modification, Capillary-Driven Microfluidic Control, and Signal Amplification by Redox cycling", Electroanalysis 2010; 22(19),2235-2244. (IF: 2.63) (Epub Jul 22;Oct)
64. Lee E, Lee J and Jon S*. “A Novel Approach to Oral Delivery of Insulin by Conjugating with Low Molecular Weight Chitosan”, Bioconjugate Chem, 2010; 21,1720-1723 (IF: 4.35) (Epub Sep 17)
63. Yu MK, Park J, Jeong YY, Moon WK and Jon S*. “Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery”, Nanotechnology, 2010; 21(41), 415102. (IF: 3.14) (Oct 15; Epub Sep 17)
62. Kim D, Jeong YY and Jon S*. “A Drug-Loaded Aptamer-Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer”, ACS Nano, 2010; 4, 3689-3696. (IF: 7.49) (Jul 27; Epub Jun 15)
61. Saw PE, Ko YT and Jon S*. “Efficient Liposomal Nanocarrier-mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell-Penetrating Peptide as a Packaging and Intracellular Delivery Agent”, Macromol. Rapid Commun, 2010; 31(13), 1155-1162. (IF: 4.26) (Epub May 20) Selected as a Back Cover Paper
60. Yu MK, Lee S, Chang S* and Jon S*. “NTA•Ni2+-Functionalized Quantum Dots for VAMP2 Labeling in Live Cells”, Bull. Korean. Chem. Soc., 2010; 31(6), 1474-1478. (IF: 1.26) (June 20)
59. Namgung R, Singha K, Yu MK, Jon S, Kim YS, Park IK and Kim WJ*. “Hybrid superparamagnetic iron oxide nanoparticle-branched polyethyleneimine magnetoplexes for gene transfection of vascular endothelial cells”, Biomaterials, 2010; 31(14), 4204-4213. (IF: 7.37) (May; Epub Feb 18)
58. Das J, Kim H, Jo K, Park KH, Jon S, Lee K and Yang H*. “Fast Catalytic and Electrocatalytic Oxidation of Sodium Borohydride on Palladium Nanoparticles and Its Application to Ultrasensitive DNA Detection”, Chem. Commun, 2009; 6394-6396. (IF: 5.34) (Nov 14; Epub Oct 1)
57. Sung D, Park S and Jon S*. “Facile Method for Selective Immobilization of Biomolecules on Plastic Surfaces”, Langmuir, 2009; 25, 11289-11294. (IF: 4.10) (Oct 6; Epub Sep 09)
56. Lee E, Kim H, Lee IH and Jon S*. “In Vivo Antitumor Effects of Chitosan-Conjugated Docetaxel after Oral Administration”, J. Control. Release., 2009; 140, 79-85. (IF: 5.69) (Dec 3; Epub Aug 24) Selected as a Cover Paper.
55. Hue J, Lee B, Kang B, Kim J, Chai H, Jo K, Yu MK, Jon S, Jeong J, Kim J and Han B*. “In Vivo Kinetics of Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles in Rats”, J. Am. Assoc. Lab. Animal Sci., 2009; 48, 621-622. (IF: 0.95) (Sep)
54. Kim J, Hue J, Kang B, Kim J, Chai H, Lee B, Jeong J, Jon S, Han B, Yu MK and Jo K*. “In Vivo Distribution of Cy5.5-Conjugated Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles in Mice”, J. Am. Assoc. Lab. Animal Sci., 2009; 48, 624. (IF: 0.95) (Sep)
53. Park J, Yu MK, Jeong YY, Kim JW, Lee K, Phan VN and Jon S*. “Antibiofouling, amphiphilic polymer-coated superparamagnetic iron oxide nanoparticles: synthesis, characterization, and use in cancer imaging in vivo”, J. Mater. Chem., 2009; 19, 6412-6417. (IF: 4.65) (Epub Jun 10)
52. Kim D, Kim JW, Jeong YY* and Jon S*. “Antibiofouling Polymer Coated Gold@Iron Oxide Nanoparticle as a Dual Contrast Agent for CT and MRI”, Bull. Korean. Chem. Soc., 2009; 30, 1855-1857. (IF: 1.26) (Jul ?)
51. Cho WS, Cho M, Kim SR, Choi M, Lee JY, Han BS, Park S, Yu MK, Jon S, Jeong J*. “Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging”, Toxicol Appl Pharm., 2009; 239, 106-115. (IF: 3.36) (Aug 15; Epub Jun 9).
50. Kim S, Park JW, Kim D, Kim D and Jon S*. “Bioinspired Colorimetric Detection of Calcium Ion in Serum Using Calsequestrin-Functionalized Gold Nanoparticles”, Angew. Chem. Int. Ed., 2009; 48, 4138-4141. (IF: 10.88) (Epub May 7 ). Selected as a Hot Paper.
49. Park S, Kim YS, Kim WB* and Jon S*. “Carbon Nanosyringe Array as a Platform for Intracellular Delivery”, Nano Lett., 2009; 9(4), 1325-1329. (IF: 10.37) (Apr; Epub Mar 2) Highlighted in “Nanowerk Magazine” and “Nature Asia Materials”.
48. Bagolkot V, Lee IH, Yu MK, Lee E, Park S, Lee JH and Jon S*. “A Combined Chemoimmunotherapy Approach Using a Plasmid-Doxorubicin Complex”, Mol. Pharm., 2009; 6(3), 1019-1028. (IF: 4.57) (Epub Apr 1)
47. Das J, Huh CH, Kwon K, Park S, Jon S and Yang H*. “Comparison of the Nonspecific Binding of DNA-Conjugated Gold Nanoparticles between Polymeric and Monomeric Self-Assembled Monolayers”, Langmuir, 2009; 25(1), 235-241. (IF: 4.10) (Dec 31; Epub Nov 25)
46. Lee E, Lee J, Lee IH, Yu M, Kim H, Chae SY and Jon S*. “Conjugated Chitosan as a Novel Platform for Oral Delivery of Paclitaxel”, J. Med. Chem, 2008; 51(20), 6442-6449. (IF: 4.95) (Oct 23; Epub Oct 1)
44. Yu MK, Jeong YY, Park JH, Park SJ, Kim JW, Min JJ, Kim KW and Jon S*. “Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo”, Angew. Chem. Int. Ed., 2008; 47, 5362-5365. (IF: 10.03) (July 7; Epub Jun 12)
43. Kim EJ, Shin HY, Park S, Sung D, Jon S*, Sampathkumar SG, Yarema KJ, Choi SY, and Kim K*. “Electrochemically active, anti-biofouling polymer adlayers on indium-tin-oxide electrodes”, Chem. Commun. 2008; 3543-3545. (IF: 5.14) (Aug 14; Epub May 30)
42. Park S, Yang HS, Kim D, Jo K and Jon S*. “Rational design of amphiphilic polymers to make carbon nanotubes water-dispersible, anti-biofouling, and functionalizable”, Chem. Commun. 2008; 2876-2878. (IF: 5.14) (Jul 7; Epub Apr 17) Highlighted in “Chemical Science” and in “Chemistry World” (the RSC’s monthly magazine).
41. Horvath G, Premkumar T, Boztas A, Lee E, Jon S and Geckeler KE. “Supramolecular Nanoencapsulation as a Tool: Solubilization of the Anticancer Drug trans-Dichloro(dipyridine)platinum(II) by Complexation with beta-Cyclodextrin”, Mol. Pharm. 2008; 5, 358-363. (IF: 11.5) (Epub Feb 19)
40. Lee BS, Park S, Lee KB, Jon S* and Choi IS*. “Selective immobilization of biomolecules onto an activated polymeric adlayer”, Biointerphases 2007; 2, 136-142. (Nov 8) Top 20 Most Downloaded Articles during March 2008.
38. Jung J, Lee IH, Lee E, Park JH and Jon S*. “pH-Sensitive Polymer Nanospheres for Use as a Potential Drug Delivery Vehicle”, Biomacromolecules, 2007; 8, 3401-3407. (IF: 3.66) (Epub Oct 16)
37. Park S, Lee KB, Choi IS and Jon S*. “Dual Functional, Polymeric Self-Assembled Monolayers as a Facile Platform for Construction of Patterns of Biomolecules”, Langmuir 2007; 23, 10902-10905. (IF: 3.90) (Oct 23; Epub Sep 28)
36. Lee H, Yu MK, Park S, Moon S, Min JJ, Jeong YY* and Jon S*. “Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles: Synthesis and Application as a Dual Imaging Probe for Cancer in Vivo”, J. Am. Chem. Soc., 2007; 129, 12739-12745. (IF: 7.70) (Oct 24; Epub Sep 25) Highlighted in “Biophotonics International” (December, 2007).
35. Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S*, Kantoff PW, Langer R and Farokhzad OC*. “Quantum Dot-Aptamer Conjugates for Synchronous Cancer Imaging, Therapy and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer”, Nano Lett. 2007; 7, 3065-3070. (IF: 9.96) (Oct; Epub Sep 14) Highlighted in “Biophotonics International” (December, 2007)
34. Cho WK, Park S, Jon S* and Choi IS*. “Water-Repellent Coating: Formation of Polymeric Self-Assembled Monolayers on Nanostructured Surfaces”, Nanotechnology 2007; 18, 395602 (7ps). (IF: 3.04) (Epub Sep 4)
33. Zhang L, Radovic-Moreno AF, Alexis F, Gu FX, Basto PA, Bagalkot V, Jon S, Langer R and Farokhzad OC*. “Co-Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle-Aptamer Bioconjugates”, ChemMedChem 2007; 2, 1268-1271. (IF: 2.85) (Sep; Epub Jun 28)
32. Kim D, Park S, Lee JH, Jeong YY* and Jon S*. “Antibiofouling Polymer-Coated Gold Nanoparticles as a Contrast Agent for in Vivo X-ray Computed Tomography Imaging”, J. Am. Chem. Soc., 2007; 129, 7661-7665. (IF: 7.70) (Jun 20; Epub May 27)
31. Aziz MA, Park S, Jon S and Yang H*. “Amperometric immunosensing using an indium tin oxide electrode modified with multi-walled carbon nanotube and poly(ethylene glycol)-silane copolymer”, Chem. Commun. 2007; 2610-2612. (IF: 4.52) (Jul 7; Epub Apr 3)
30. Choi J, Kim J, Kim K,* Yang ST, Kim JI and Jon S*. “A Rationally Designed Macrocyclic Cavitand That Kills Bacteria with High Efficacy and Good Selectivity”, Chem. Commun., 2007; 1151-1153. (IF: 4.52)
29. Bagolkot V, Farokhzad OC,* Langer R and Jon S*. “An Aptamer-Doxorubicin Physical Conjugate as A Novel Targeted Drug Delivery Platform”, Angew. Chem. Int. Ed., 2006; 45, 8149-8152.(IF: 9.60)
28. Park S, Chi YS, Choi IS, Seong J* and Jon S*. “A Facile Method for Construction of Antifouling Surfaces by Self-Assembled Polymeric Monolayers of PEG-Silane Copolymers Formed in Aqueous Medium”, J. Nanosci. Nanotechnol. 2006, 6 (11), 3507-3511.